Keaton M Crosse

5PUBLICATIONS
18CO-AUTHORS
Proteins and peptidesInfectious diseasesGenetically modified animalsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 09, 2025
Host cell and viral protease targets of human SERPINs identified by in silico docking.

Joaquin Rodriguez Galvan, Maren de Vries, Shiraz Belblidia

|Oct 13, 2023
Generation of quality-controlled SARS-CoV-2 variant stocks.

Maren de Vries, Grace O Ciabattoni, Bruno A Rodriguez-Rodriguez

|Nov 23, 2022
In-silico docking platform with serine protease inhibitor (SERPIN) structures identifies host cysteine protease targets with significance for SARS-CoV-2.

Joaquín J Rodriguez Galvan, Maren de Vries, Shiraz Belblidia

|Oct 14, 2022
A neonatal mouse model characterizes transmissibility of SARS-CoV-2 variants and reveals a role for ORF8.

Bruno A Rodriguez-Rodriguez, Grace O Ciabattoni, Ralf Duerr

|Nov 01, 2020
Viperin binds STING and enhances the type-I interferon response following dsDNA detection.

Keaton M Crosse, Ebony A Monson, Arti B Dumbrepatil

Pageof 1